Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (871-880 of 934) with videos related to

Pageof 94
Sort By:
American Heart Journal|June 2, 2020
In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular eventsHarvey D White, Ralph A H Stewart, Anthony J Dalby, et al.
Journal of the American College of Cardiology|July 7, 2012
An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trialsMichelle L O'Donoghue, Ajay Vaidya, Rizwan Afsal, et al.
The American Journal of Medicine|May 12, 2020
Comparison of Dabigatran Plus a P2Y<sub>12</sub> Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCIRaffaele De Caterina, Antonio Procopio, José-Luis Lopez Sendon, et al.
Journal of the American College of Cardiology|October 27, 2022
Cardiovascular Effects of Canagliflozin in Relation to Renal Function and AlbuminuriaAshish Sarraju, George Bakris, Christopher P Cannon, et al.
Circulation|April 7, 2024
Randomized Evaluation of a Remote Management Program to Improve Guideline-Directed Medical Therapy: The DRIVE TrialAlexander J Blood, Lee-Shing Chang, Shahzad Hassan, et al.
Primary Care Diabetes|February 1, 2024
Methods, rationale, and design for a remote pharmacist and navigator-driven disease management program to improve guideline-directed medical therapy in patients with type 2 diabetes at elevated cardiovascular and/or kidney riskAlexander J Blood, Lee-Shing Chang, Caitlin Colling, et al.
American Heart Journal|January 5, 2021
Risk markers of incident atrial fibrillation in patients with coronary heart diseaseMaria Tomasdottir, Claes Held, Nermin Hadziosmanovic, et al.
European Heart Journal|April 3, 2009
Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromesDeepak L Bhatt, Eric D Peterson, Robert A Harrington, et al.
The American Journal of Cardiology|October 24, 2006
Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE)Pierluigi Tricoci, Eric D Peterson, Jyotsna Mulgund, et al.
The New England Journal of Medicine|August 29, 2017
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial FibrillationChristopher P Cannon, Deepak L Bhatt, Jonas Oldgren, et al.
Pageof 94

Showing results (871-880 of 934) with videos related to

Sort By:
Pageof 94
American Heart Journal|June 2, 2020
In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular eventsHarvey D White, Ralph A H Stewart, Anthony J Dalby, et al.
Journal of the American College of Cardiology|July 7, 2012
An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trialsMichelle L O'Donoghue, Ajay Vaidya, Rizwan Afsal, et al.
The American Journal of Medicine|May 12, 2020
Comparison of Dabigatran Plus a P2Y<sub>12</sub> Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCIRaffaele De Caterina, Antonio Procopio, José-Luis Lopez Sendon, et al.
Journal of the American College of Cardiology|October 27, 2022
Cardiovascular Effects of Canagliflozin in Relation to Renal Function and AlbuminuriaAshish Sarraju, George Bakris, Christopher P Cannon, et al.
Circulation|April 7, 2024
Randomized Evaluation of a Remote Management Program to Improve Guideline-Directed Medical Therapy: The DRIVE TrialAlexander J Blood, Lee-Shing Chang, Shahzad Hassan, et al.
Primary Care Diabetes|February 1, 2024
Methods, rationale, and design for a remote pharmacist and navigator-driven disease management program to improve guideline-directed medical therapy in patients with type 2 diabetes at elevated cardiovascular and/or kidney riskAlexander J Blood, Lee-Shing Chang, Caitlin Colling, et al.
American Heart Journal|January 5, 2021
Risk markers of incident atrial fibrillation in patients with coronary heart diseaseMaria Tomasdottir, Claes Held, Nermin Hadziosmanovic, et al.
European Heart Journal|April 3, 2009
Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromesDeepak L Bhatt, Eric D Peterson, Robert A Harrington, et al.
The American Journal of Cardiology|October 24, 2006
Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE)Pierluigi Tricoci, Eric D Peterson, Jyotsna Mulgund, et al.
The New England Journal of Medicine|August 29, 2017
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial FibrillationChristopher P Cannon, Deepak L Bhatt, Jonas Oldgren, et al.
Pageof 94